Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
United States Natural Gas Fund
UNG
$478M
| $1.35M | ﹤0.01% |
66,516
+31,501
| +90% | +$784K |
|
3152
Cogent Biosciences
COGT
$7.24B
| $1.35M | ﹤0.01% |
229,205
+118,293
| +107% | +$906K |
|
3153
Standard Motor Products
SMP
$911M
| $1.34M | ﹤0.01% |
33,781
+18,184
| +117% | +$648K |
|
3154
Fate Therapeutics
FATE
$326M
| $1.34M | ﹤0.01% |
359,375
+240,624
| +203% | +$568K |
|
|
OKYO
3155
OKYO Pharma
OKYO
$78.2M
| $1.34M | ﹤0.01% |
758,333
+733,333
| +2,933% | +$1.29M |
|
3156
Central Pacific Financial
CPF
$1B
| $1.34M | ﹤0.01% |
68,095
+16,973
| +33% | +$297K |
|
3157
VSE Corp
VSEC
$6.12B
| $1.34M | ﹤0.01% |
20,708
+15,534
| +300% | +$912K |
|
|
SPR
3158
CALL
DELISTED
Spirit AeroSystems
SPR
| $1.34M | ﹤0.01% |
+42,100
| New | +$1.03M |
|
3159
Amylyx Pharmaceuticals
AMLX
$2.54B
| $1.34M | ﹤0.01% |
90,879
+65,180
| +254% | +$999K |
|
3160
CALL
Agios Pharmaceuticals
AGIO
$1.93B
| $1.34M | ﹤0.01% |
+60,000
| New | +$1.34M |
|
|
3161
PUT
Agios Pharmaceuticals
AGIO
$1.93B
| $1.34M | ﹤0.01% |
+60,000
| New | +$1.34M |
|
3162
NRC Health Common Stock
NRC
$450M
| $1.34M | ﹤0.01% |
33,748
+23,264
| +222% | +$974K |
|
3163
Global X Uranium ETF
URA
$6.27B
| $1.33M | ﹤0.01% |
48,171
-3,805
| -7% | -$104K |
|
3164
Pegasystems
PEGA
$5.38B
| $1.33M | ﹤0.01% |
54,462
+23,400
| +75% | +$547K |
|
|
RWT
3165
Redwood Trust
RWT
$594M
| $1.33M | ﹤0.01% |
179,098
+123,372
| +221% | +$865K |
|
|
BASE
3166
DELISTED
Couchbase
BASE
| $1.32M | ﹤0.01% |
58,836
+42,384
| +258% | +$777K |
|
3167
CALL
Ironwood Pharmaceuticals
IRWD
$714M
| $1.32M | ﹤0.01% |
115,800
-48,600
| -30% | -$481K |
|
3168
Zillow
ZG
$7.63B
| $1.32M | ﹤0.01% |
23,350
+3,820
| +20% | +$164K |
|
3169
Lemonade
LMND
$4.1B
| $1.32M | ﹤0.01% |
82,015
+60,574
| +283% | +$913K |
|
3170
PUT
IonQ
IONQ
$16.6B
| $1.32M | ﹤0.01% |
+106,600
| New | +$1.37M |
|
|
AL
3171
DELISTED
Air Lease Corp
AL
| $1.32M | ﹤0.01% |
31,479
-20,651
| -40% | -$782K |
|
3172
Blue Bird Corp
BLBD
$2.18B
| $1.32M | ﹤0.01% |
48,930
-172,297
| -78% | -$3.55M |
|
3173
Adtran
ADTN
$616M
| $1.32M | ﹤0.01% |
179,243
+86,603
| +93% | +$571K |
|
3174
Skyward Specialty Insurance
SKWD
$2.58B
| $1.31M | ﹤0.01% |
38,734
+22,240
| +135% | +$684K |
|
3175
Mercantile Bank Corp
MBWM
$1.05B
| $1.31M | ﹤0.01% |
32,480
+16,221
| +100% | +$568K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.